CEO of Doudna spinout: Within five years, genome editors will have a 'really big impact' on patients' lives
Endpoints News
|
August 12, 2022
X min read
Endpoints News
|
August 12, 2022
Share on Social
More like this
News
Scribe Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
December 15, 2025
Read Now
Press
Scribe Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
December 15, 2025
Read Now
